Leveraging Generative AI to restore vision: a journey into the brain.

Dandelion Science, a patented US-Swiss Generative Neuromodulation™ company, funded by the NIH and the Swiss Innovation Agency, proudly announces it is the recipient of the Breakthrough Technology Award from The American Macular Degeneration Foundation (AMDF). 

“Dandelion’s approach could transform vision treatment paradigms by shifting the focus from the eye to how the brain processes information. The AMDF is excited to support Dandelion’s endeavors with this funding,” says Matthew Levine, AMDF. 

Novel findings from research funded by the AMDF are being presented this week at the Association for Research in Vision and Ophthalmology (ARVO) hashtag#ARVO2024.